In this, the second of two Commentaries, Sibylle Gaisser, Michael M. Hopkins and colleagues discuss a survey demonstrating that European health-care systems are ill prepared for the commercial reality of gene patents.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Aymé, S., Matthijs, G. & Soini, S. Eur. J. Hum. Genet. 16, S3–S9 (2008).
Carlson, B. Genet. Eng. News 29, 14–15 (2009).
Matthijs, G. & Hodgson, S. Clin. Med. 8, 58–60 (2008).
Lacasa, I. D., Reiss, T. & Senker, J. Sci. Pub. Policy 31, 385–395 (2004).
Hopkins, M. M., Mahdi, S., Thomas, S. M. & Patel, P. The Patenting of Human DNA: Global Trends in the Granting, Filing and Exploitation of DNA Patents. A report for the European Commission Sixth Framework Programme (SPRU, 2006). Available at http://www.sussex.ac.uk/spru/documents/patgen_finalreport.pdf
Cho, M. K., Illangasekare, S., Weaver M. A., Leonard, D. G. B., & Merz J. F . J. Mol Diagn. 5, 3–8 (2003).
Zika, E., Gurwitz, D. & Ibarreta, D. Pharmacogenetics and Pharmacogenomics: State-of-the-art and Potential Socio-Economic Impacts in the EU (Institute for Prospective Technical Studies, 2006). Available at http://ftp.jrc.es/EURdoc/eur22214en.pdf
Hopkins, M. M, Mahdi, S., Patel, P. & Thomas, S. M. Nature Biotechnol. 25, 185–187 (2007).
Development and Implications of Patent Law in the Field of Biotechnology and Genetic Engineering Report from the Commission to the Council and the European Parliament (2005). Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2005:0312:FIN:EN:PDF
Matthijs, G. Br. Med. J. 329, 1358–1360 (2004).
Author information
Authors and Affiliations
Additional information
This article represents the authors' opinions and not those of the European Commission. See Editorial, page 386 , and online at http://tinyurl.com/dlnksh .
Rights and permissions
About this article
Cite this article
Gaisser, S., Hopkins, M., Liddell, K. et al. The phantom menace of gene patents. Nature 458, 407–408 (2009). https://doi.org/10.1038/458407a
Published:
Issue date:
DOI: https://doi.org/10.1038/458407a
This article is cited by
-
Continental drift? Do European clinical genetic testing laboratories have a patent problem?
European Journal of Human Genetics (2019)
-
D’Arcy v. Myriad Genetics: A Demand for the “Made” or “Non-Information” and Clear Subject Matter?
IIC - International Review of Intellectual Property and Competition Law (2016)
-
Are the gene-patent storm clouds dissipating? A global snapshot
Nature Biotechnology (2015)
-
Harm, hype and evidence: ELSI research and policy guidance
Genome Medicine (2013)
-
Biomarker patents for diagnostics: problem or solution?
Nature Biotechnology (2012)
